JP2013528589A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528589A5 JP2013528589A5 JP2013509213A JP2013509213A JP2013528589A5 JP 2013528589 A5 JP2013528589 A5 JP 2013528589A5 JP 2013509213 A JP2013509213 A JP 2013509213A JP 2013509213 A JP2013509213 A JP 2013509213A JP 2013528589 A5 JP2013528589 A5 JP 2013528589A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- composition according
- hyperbranched polymer
- active ingredient
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960003933 dorzolamide Drugs 0.000 claims description 2
- IAVUPMFITXYVAF-XPUUQOCRSA-N dorzolamide Chemical compound CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 IAVUPMFITXYVAF-XPUUQOCRSA-N 0.000 claims description 2
- 229920000587 hyperbranched polymer Polymers 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 4
- 239000002876 beta blocker Substances 0.000 claims 3
- 229940097320 beta blocking agent Drugs 0.000 claims 3
- IWEGDQUCWQFKHS-UHFFFAOYSA-N 1-(1,3-dioxolan-2-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole Chemical group O1C(C)(C)C(C)(C)OB1C1=CN(CC2OCCO2)N=C1 IWEGDQUCWQFKHS-UHFFFAOYSA-N 0.000 claims 2
- PTBDIHRZYDMNKB-UHFFFAOYSA-N 2,2-Bis(hydroxymethyl)propionic acid Chemical group OCC(C)(CO)C(O)=O PTBDIHRZYDMNKB-UHFFFAOYSA-N 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 230000003796 beauty Effects 0.000 claims 2
- 229960001724 brimonidine tartrate Drugs 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 229920002873 Polyethylenimine Polymers 0.000 claims 1
- 229960000571 acetazolamide Drugs 0.000 claims 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 claims 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 claims 1
- 229960004324 betaxolol Drugs 0.000 claims 1
- NWIUTZDMDHAVTP-UHFFFAOYSA-N betaxolol Chemical compound C1=CC(OCC(O)CNC(C)C)=CC=C1CCOCC1CC1 NWIUTZDMDHAVTP-UHFFFAOYSA-N 0.000 claims 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 claims 1
- 229960001222 carteolol Drugs 0.000 claims 1
- LWAFSWPYPHEXKX-UHFFFAOYSA-N carteolol Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(O)CNC(C)(C)C LWAFSWPYPHEXKX-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 229960000831 levobunolol Drugs 0.000 claims 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 claims 1
- 229960002704 metipranolol Drugs 0.000 claims 1
- BQIPXWYNLPYNHW-UHFFFAOYSA-N metipranolol Chemical compound CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C BQIPXWYNLPYNHW-UHFFFAOYSA-N 0.000 claims 1
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- 229920000333 poly(propyleneimine) Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 229960003712 propranolol Drugs 0.000 claims 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229940069275 cosopt Drugs 0.000 description 1
- OSRUSFPMRGDLAG-QMGYSKNISA-N dorzolamide hydrochloride Chemical compound [Cl-].CC[NH2+][C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 OSRUSFPMRGDLAG-QMGYSKNISA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/774,419 US8211450B2 (en) | 2010-05-05 | 2010-05-05 | Ophthalmic composition |
| US12/774,419 | 2010-05-05 | ||
| PCT/US2011/035147 WO2011140194A1 (en) | 2010-05-05 | 2011-05-04 | Ophthalmic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013528589A JP2013528589A (ja) | 2013-07-11 |
| JP2013528589A5 true JP2013528589A5 (enExample) | 2015-02-19 |
Family
ID=44902332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509213A Pending JP2013528589A (ja) | 2010-05-05 | 2011-05-04 | 眼科用組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8211450B2 (enExample) |
| EP (1) | EP2566487A4 (enExample) |
| JP (1) | JP2013528589A (enExample) |
| KR (1) | KR20130121685A (enExample) |
| CN (1) | CN103096901A (enExample) |
| CA (1) | CA2797123A1 (enExample) |
| MX (1) | MX2012012846A (enExample) |
| WO (1) | WO2011140194A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201500501A1 (ru) * | 2010-07-29 | 2015-12-30 | Сантен Фармасьютикал Ко., Лтд. | Несущий корпус для лекарственного средства и способ его изготовления |
| WO2013114397A2 (en) * | 2012-01-16 | 2013-08-08 | Biocon Limited | Pharmaceutically acceptable salt of brinzolamide and composition thereof |
| US9820991B2 (en) * | 2013-11-08 | 2017-11-21 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
| CN103740831B (zh) * | 2014-01-13 | 2015-01-28 | 宁波海尔施基因科技有限公司 | 一种指导β-受体阻断药用药的引物组合物、多重基因检测试剂盒及其使用方法 |
| PT3096740T (pt) * | 2014-01-24 | 2020-12-24 | Sentiss Pharma Private Ltd | Composição farmacêutica que compreende brinzolamida |
| PT3142993T (pt) | 2014-05-16 | 2018-12-18 | Occidental Chem Co | Método para preparar 1,1,3,3-tetracloropropeno |
| AU2015288644B2 (en) * | 2014-07-11 | 2017-12-14 | Fujifilm Corporation | Aqueous ophthalmic composition |
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| KR101773669B1 (ko) | 2015-07-30 | 2017-08-31 | 포항공과대학교 산학협력단 | 생체적합성 각막세포 전구체 분화방법 및 각막세포 전구체 조성물 |
| JP6050454B1 (ja) * | 2015-09-28 | 2016-12-21 | 参天製薬株式会社 | 水性医薬組成物 |
| TW201733577A (zh) * | 2016-03-14 | 2017-10-01 | Santen Pharmaceutical Co Ltd | 含有多佐胺、噻嗎洛爾和界面活性劑之醫藥組成物 |
| KR20250057155A (ko) | 2017-12-15 | 2025-04-28 | 타르서스 파마수티칼스, 아이엔씨. | 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법 |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| WO2021018750A1 (en) | 2019-07-26 | 2021-02-04 | Proqr Therapeutics Ii B.V. | Ophthalmic compositions comprising viscosifying polymers and nucleic acids |
| EP4467144A4 (en) * | 2022-01-21 | 2026-01-21 | Senju Usa Inc | AQUEOUS LIQUID FORMULATION |
| CN118978426B (zh) * | 2024-10-22 | 2025-05-16 | 浙江大学 | 一种甘油的酸化处理方法、酸化甘油及其应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5136014A (en) * | 1990-06-22 | 1992-08-04 | E. I. Du Pont De Nemours And Company | Hyperbranched polyesters |
| WO1992018124A1 (en) * | 1991-04-17 | 1992-10-29 | Merck & Co., Inc. | OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST |
| US6316443B1 (en) * | 1994-08-04 | 2001-11-13 | Merck & Co., Inc. | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist |
| DE19726186A1 (de) * | 1997-06-20 | 1998-12-24 | Boehringer Ingelheim Int | Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen |
| FR2772771B1 (fr) * | 1997-12-19 | 2000-01-28 | Oreal | Utilisation de polymeres hyperbranches et de dendrimeres comportant un groupement particulier, en tant qu'agent filmogene, les compositions filmogenes les comprenant et leur utilisation notamment en cosmetique ou en pharmacie |
| WO2000063409A1 (en) | 1999-04-21 | 2000-10-26 | Massachusetts Institute Of Technology | Endosomolytic agents and cell delivery systems |
| US7030097B1 (en) | 1999-07-14 | 2006-04-18 | Cornell Research Foundation, Inc. | Controlled nucleic acid delivery systems |
| SK282717B6 (sk) | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
| US7097856B2 (en) | 2000-09-29 | 2006-08-29 | The Regents Of The University Of California | Dendrimeric support or carrier macromolecule |
| WO2002067908A1 (en) | 2001-02-26 | 2002-09-06 | Duke University | Novel dendritic polymers and their biomedical uses |
| BR0207638A (pt) | 2001-03-08 | 2004-07-27 | Nymox Pharmaceuticals Corp | Métodos de uso de proteìna de filamento neural para tratar tumores e outras condições que requerem a remoção ou destruição de células |
| FR2830450B1 (fr) * | 2001-10-09 | 2004-02-06 | Univ Pasteur | Utilisation de dendrimeres dans une composition ophtalmique |
| TWI255224B (en) | 2002-01-09 | 2006-05-21 | Novartis Ag | Polymeric articles having a lubricious coating and method for making the same |
| GB0209022D0 (en) | 2002-04-19 | 2002-05-29 | Imp College Innovations Ltd | Compounds |
| AU2003293529A1 (en) | 2002-12-16 | 2004-07-29 | Nitromed, Inc. | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| NZ574134A (en) * | 2003-02-13 | 2011-03-31 | Dimitrios Tsiourvas | Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| JP2005008614A (ja) | 2003-03-28 | 2005-01-13 | Nano Career Kk | 高分子ミセルを用いた眼科用ドラッグデリバリーシステム |
| US7109247B2 (en) | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
| US7189456B2 (en) | 2004-03-04 | 2007-03-13 | Transitions Optical, Inc. | Photochromic optical article |
| WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
| US20060057215A1 (en) * | 2004-09-15 | 2006-03-16 | Raiche Adrian T | Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility |
| US7837986B2 (en) | 2004-12-01 | 2010-11-23 | E. I. Du Pont De Nemours And Company | Protein-based polymer tissue adhesives for medical use |
| WO2006087227A2 (de) * | 2005-02-21 | 2006-08-24 | Basf Aktiengesellschaft | Wirkstoffzusammensetzung die wenigstens ein stickstoffatomhaltiges hyperverweigtes polymer enthält |
| US20060257359A1 (en) | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
| US8679536B2 (en) | 2005-08-24 | 2014-03-25 | Actamax Surgical Materials, Llc | Aldol-crosslinked polymeric hydrogel adhesives |
| US7666331B2 (en) | 2005-08-31 | 2010-02-23 | Transitions Optical, Inc. | Photochromic article |
| JP5989294B2 (ja) | 2006-01-20 | 2016-09-07 | スターファーマ・プロプライエタリー・リミテッドＳｔａｒｐｈａｒｍａ Ｐｔｙ Ｌｔｄ | 修飾高分子 |
| US20090012033A1 (en) | 2006-03-03 | 2009-01-08 | Demattei Cordell R | Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers) |
| US20080031916A1 (en) * | 2006-04-24 | 2008-02-07 | Heather Sheardown | Dendrimer cross-linked collagen |
| WO2008027340A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
| US20090324742A1 (en) | 2006-09-08 | 2009-12-31 | Sonke Svenson | Peham dendrimers as excipients |
| CN101553206B (zh) * | 2006-11-09 | 2012-11-21 | 爱尔康研究有限公司 | 用于药物递送的水不溶性聚合物基质 |
| US7906214B2 (en) | 2007-01-26 | 2011-03-15 | Transitions Optical, Inc. | Optical elements comprising compatiblizing coatings and methods of making the same |
| HUE055815T2 (hu) * | 2007-10-05 | 2021-12-28 | Univ Wayne State | Vegyületek nyújtott felszabadítására alkalmas dendrimerek |
| US8426492B2 (en) | 2007-11-14 | 2013-04-23 | Actamax Surgical Materials, Llc | Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use |
| US20100008993A1 (en) | 2008-07-14 | 2010-01-14 | Proksch Joel W | Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs |
| WO2010017184A2 (en) * | 2008-08-08 | 2010-02-11 | Virginia Commonwealth University | Dendrimer hydrogels |
-
2010
- 2010-05-05 US US12/774,419 patent/US8211450B2/en not_active Expired - Fee Related
-
2011
- 2011-05-04 EP EP20110778244 patent/EP2566487A4/en not_active Withdrawn
- 2011-05-04 CA CA2797123A patent/CA2797123A1/en not_active Abandoned
- 2011-05-04 WO PCT/US2011/035147 patent/WO2011140194A1/en not_active Ceased
- 2011-05-04 US US13/695,930 patent/US20130053374A1/en not_active Abandoned
- 2011-05-04 CN CN2011800332340A patent/CN103096901A/zh active Pending
- 2011-05-04 JP JP2013509213A patent/JP2013528589A/ja active Pending
- 2011-05-04 KR KR1020127031915A patent/KR20130121685A/ko not_active Withdrawn
- 2011-05-04 MX MX2012012846A patent/MX2012012846A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528589A5 (enExample) | ||
| CA2797123A1 (en) | Ophthalmic composition | |
| TWI323274B (en) | Polishing composition and method for high silicon nitride to silicon oxide removal rate ratios | |
| TWI313703B (en) | Cmp composition comprising surfactant | |
| JP2011530166A5 (enExample) | ||
| JP6001858B2 (ja) | 非イオン性ポリマーを含有するスラリー組成物とその使用方法 | |
| JP2018513229A5 (enExample) | ||
| TW201525121A (zh) | 用於選擇性移除氮化矽之化學機械拋光（ｃｍｐ）組合物及方法 | |
| WO2012142374A3 (en) | Compositions and methods for selective polishing of silicon nitride materials | |
| JP2013537874A5 (enExample) | ||
| MX2014005560A (es) | Composiciones de tratamiento de superficie que incluyen sales protectoras. | |
| CL2008000243A1 (es) | Formulacion en granulos solubles de acido 2-cis,4-trans-(s)-abscisico; proceso de fabricacion; y metodo para mejorar la estabilidad al almacenamiento y la estabilidad fotoquimica. | |
| JP2010150292A5 (enExample) | ||
| EP2576721A4 (en) | TENSIDLESS ALKALI POLYMER FORMULATIONS FOR THE RECONSTRUCTION OF REACTIVE CRUDE OIL | |
| WO2010111576A3 (en) | Aminated polymers and their use in water-borne compositions | |
| JP2016201557A (ja) | シリコンウエハ研磨用組成物 | |
| TW201237154A (en) | Polishing composition, method for polishing using the same, and method for producing substrate | |
| WO2012004082A3 (de) | Quartäre-aminoalkoholfunktionelle, siliciumorganische verbindungen, diese enthaltende zusammensetzung sowie deren herstellung und verwendung | |
| TW201241171A (en) | Water-soluble working fluid for fixed abrasive grain wire saw | |
| RU2012117238A (ru) | Густые кислотные абразивные чистящие составы | |
| JP2012172117A5 (enExample) | ||
| AR080076A1 (es) | Producto de cuidado oral para el cuidado de esmalte sensible | |
| AU2012262405A8 (en) | Amphoteric polymer composition | |
| CN103391993B (zh) | 包含巯基吡啶氧化物源的条皂 | |
| WO2011073222A3 (de) | Hyperverzweigte polyester mit hydrophobem kern zur solubilisierung schwerlöslicher wirkstoffe |